hidradenitis suppurativa
Showing 51 - 75 of 142
Hidradenitis Suppurativa Trial (Deroofing and laser)
Not yet recruiting
- Hidradenitis Suppurativa
- Deroofing and laser
- (no location specified)
Jul 29, 2022
Hidradenitis Suppurativa Trial (NovaSorb® BTM, Human Cadaveric Allograft)
Not yet recruiting
- Hidradenitis Suppurativa
- NovaSorb® BTM
- Human Cadaveric Allograft
- (no location specified)
Jul 25, 2022
Hidradenitis Suppurativa, Acne Inversa Trial in New York (Brodalumab)
Completed
- Hidradenitis Suppurativa
- Acne Inversa
-
New York, New YorkThe Rockefeller University
Jul 26, 2022
Hidradenitis Suppurativa Trial in Worldwide (Bimekizumab)
Enrolling by invitation
- Hidradenitis Suppurativa
-
Birmingham, Alabama
- +136 more
Jul 26, 2022
Hidradenitis Suppurativa, Scarring Trial (Sciton laser Joule X)
Not yet recruiting
- Hidradenitis Suppurativa
- Scarring
- Sciton laser Joule X
- (no location specified)
Jul 20, 2022
Hidradenitis Suppurativa, Hyperhidrosis Trial in Pittsburgh (Botulinum toxin)
Recruiting
- Hidradenitis Suppurativa
- Hyperhidrosis
- Botulinum toxin
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh Medical Center = Presbyterian Shadyside
Jul 5, 2022
Hidradenitis Suppurativa Mail Survey
Active, not recruiting
- Hidradenitis Suppurativa
-
Winston-Salem, North CarolinaWake Forest Baptist Medical Center
Jun 28, 2022
Hidradenitis Suppurativa, Healthy Volunteers Trial in Baltimore (Radiofrequency-Based treatment)
Recruiting
- Hidradenitis Suppurativa
- Healthy Volunteers
- Radiofrequency-Based treatment
-
Baltimore, MarylandJohns Hopkins School of Medicine
Jun 28, 2022
Complement C5a Receptors in Hidradenitis Suppurativa
Recruiting
- Hidradenitis Suppurativa
-
Redwood City, CaliforniaStanford University
Jun 27, 2022
Hidradenitis Suppurativa Trial in San Francisco
Recruiting
- Hidradenitis Suppurativa
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jun 2, 2022
Abdominal Wound Dehiscence, Necrotizing Soft Tissue Infection, Lower Extremity Wound Trial in Los Angeles, New Orleans (Myriad
Recruiting
- Abdominal Wound Dehiscence
- +6 more
- Myriad Matrix™ and Myriad Morcells™
-
Los Angeles, California
- +2 more
May 16, 2022
Hidradenitis Suppurativa Trial in Miami (antibiofilm surfactant wound gel (ABWG))
Recruiting
- Hidradenitis Suppurativa
- antibiofilm surfactant wound gel (ABWG)
-
Miami, FloridaUniversity of Miami
May 9, 2022
Hidradenitis Suppurativa, Acne Inversa Trial in Worldwide (INCB054707, Placebo)
Active, not recruiting
- Hidradenitis Suppurativa
- Acne Inversa
- INCB054707
- Placebo
-
Hoover, Alabama
- +39 more
Apr 29, 2022
Hidradenitis Suppurativa, Surgical Wound Trial in Chapel Hill (Wet-to-Dry Dressings, Petrolatum with Non-Stick Gauze)
Recruiting
- Hidradenitis Suppurativa
- Surgical Wound
- Wet-to-Dry Dressings
- Petrolatum with Non-Stick Gauze
-
Chapel Hill, North CarolinaUNC School of Medicine Department of Dermatology
Apr 27, 2022
Hidradenitis Suppurativa Trial in Little Rock (Verbal consultation, Written Action Plan)
Completed
- Hidradenitis Suppurativa
- Verbal consultation
- Written Action Plan
-
Little Rock, ArkansasUniversity of Arkansas for Medical Sciences
Apr 11, 2022
Hidradenitis Suppurativa Trial in Australia (AT193)
Recruiting
- Hidradenitis Suppurativa
-
Phillip, Australian Capital Territory, Australia
- +6 more
Apr 11, 2022
Hidradenitis Suppurativa Trial in Worldwide (Bimekizumab, Adalimumab, Placebo)
Completed
- Hidradenitis Suppurativa
- Bimekizumab
- +2 more
-
Los Angeles, California
- +30 more
Mar 14, 2022
Hidradenitis Suppurativa Trial in Australia, United States (Placebo, LY3041658)
Active, not recruiting
- Hidradenitis Suppurativa
- Placebo
- LY3041658
-
Rogers, Arkansas
- +19 more
Apr 6, 2022
Immunomodulation in Hidradenitis Suppurativa and Evaluation
Not yet recruiting
- Hidradenitis Suppurativa
- Blood tests
- +2 more
-
Lille, France
- +1 more
Apr 4, 2022
Hidradenitis Suppurativa Trial in Sydney (Fostamatinib)
Recruiting
- Hidradenitis Suppurativa
-
Sydney, New South Wales, AustraliaHoldsworth House Medical Practice
Mar 15, 2022
JAK-STAT Signaling Pathway in Pyoderma Gangrenosum
Not yet recruiting
- Pyoderma Gangrenosum
- +2 more
- immunohistochemical methods
- (no location specified)
Mar 21, 2022
Hidradenitis Suppurativa Trial in Nashville (Bermekimab Monoclonal Antibody 400 mg)
Completed
- Hidradenitis Suppurativa
- Bermekimab Monoclonal Antibody 400 mg
-
Nashville, TennesseeTennessee Clinical Research Center
Feb 16, 2022
Hidradenitis Suppurativa Trial in Canada, Denmark, Germany (INCB054707, Placebo)
Completed
- Hidradenitis Suppurativa
- INCB054707
- Placebo
-
Winnipeg, Manitoba, Canada
- +12 more
Feb 25, 2022